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1 Zusammenfassung 
 
1.1 Einleitung 
Die Verwendung von Mobilgeräten und Apps ist in der Bevölkerung weitverbreitet. Die 
Benutzung dieser Technologie erlaubt den jederzeitigen Zugriff auf Informationen 
(Beispiele: Internet, Emails, Apps) wie das zuvor nie möglich war. In Großbritannien ist die 
Benützung dieser Technologie bei Assistenzärzten als Teil ihrer Arbeit und der 
Patientenbetreuung weitverbreitet. Im medizinischen Bereich hat sich die Verwendung 
dieser Technologie als eine positive Entwicklung in der Patientenbetreuung gezeigt. Diese 
Revolution fing mit der Einführung des Apple iPhone 2007 an. Der nächste entscheidende 
Schritt war die Eröffnung des Apple Appstore 2008. Dieser erlaubte das Herunterladen von 
spezifische Softwareprogrammen sogenannten “Apps” von einem Online-Geschäft und 
andere Unternehmen folgen bald darauf mit ihren eigenen Apps und Geschäften. 
1.2 Ziele der Arbeit 
Momentan ist nicht bekannt wie weit diese Technologie in der Notfallmedizin verbreitet ist 
und genutzt wird. Ziel dieser Arbeit ist die momentane Rolle von Mobilgeräten und 
medizinischen Apps in der Notfallmedizin im englisch- und deutschsprachigen Raum in 
Europa zu beschreiben und eine Übersicht zu bekommen wie medizinische Fachkräfte diese 
Technologie in ihrer täglichen Arbeit in der Notfallmedizin einsetzen. 
1.3 Methodik 
Eine web-basierte Umfrage (www.surveymonkey.com) wurden durchgeführt. Der erste Teil 
der Umfrage beschäftigte sich mit Richtlinien zur Benutzung und der Bereitstellung dieser 
Technologie an den einzelnen Institutionen im PERUKI Netzwerk. Der zweite Teil der 
Umfrage befaßte sich mit der Benutzung dieser Technologie durch einzelne medizinische 
Fachkräfte. Die Umfrage wurde durch den RCEM Newsletter, RCEM Website, soziale 
Netzwerke, das PERUKI Netzwerk und die deutsche Version durch die AAEMÖNK, DIGNA, 
ÖNK und SGNOR verteilt. 
1.4 Ergebnisse 
In der Umfrage wurde keine Schäden durch die Benutzung von medizinscher Apps 
gemeldet. Apple Geräte stellen den Großteil (70%) der institutionellen Mobilgeräte im 
PERUKI Netzwerk da und waren auch für individuelle Fachkräfte der meist benutzte 
Mobilgerätetyp. Die meisten Institutionen stellen zwischen eins bis fünf medizinische Apps 
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per Mobilgerät bereit. Die medizinischen Fachkräfte hatten die gleiche Anzahl von 
medizinischen Apps auf ihrem persönlichen Mobilgerät. Die BNF/BNFc Kompendium App 
war, die am meist installierte und empfohlene App in beiden Umfragen. Die Benützung von 
medizinischen Apps war hauptsächlich eine Frage der persönlichen Entscheidung. 
1.5 Diskussion 
In der Umfrage wurde kein Schaden durch Benutzung dieser Technologie gemeldet. Das 
Potential dafür läßt sich jedoch nicht ausschließen. Die Registrierung von medizinischen 
Apps als medizinische Geräte, zum Beispiel mit der MHRA ist eine Möglichkeit dies zu 
überwachen. Apple war der leitende Hardware Hersteller in der Umfrage. Dies hängt 
wahrscheinlich mit der langjährigen Vorreiter Stellung von Apple zusammen. Wie auch in 
vorherigen Studien waren im Durchschnitt eins bis fünf medizinische Apps pro Mobilgerät 
installiert. Das zeigt das die folgenden fünf am meisten installierten App Typen: Referenz, 
Reanimation, Kompendium, Antibiotikareferenz und medizinischer Rechner App, die am 
nützlichsten in der Notaufnahme sind. Die BNF/BNFc Kompendium App, war die am meisten 
installierte und empfohlene App. Fast die Hälfte der Fachkräfte benützen ihr persönliches 
Mobilgerät täglich um Medikamentendosen zu kontrollieren. Ungefähr ein Drittel der 
medizinischen Fachkräfte und ein Drittel der Einrichtungen benützen medizinische Apps in 
der Kinderreanimation. Im Vergleich zu 2008, als diese Technologie noch nicht existierte, 
deutet all dies auf eine größere Rolle von medizinischen Apps in der Notfallmedizin hin. 
1.6 Schlußfolgerung 
Eine Kompendium App war die am meisten verbreitete App. Die Benutzung des 
persönlichen Mobilgerätes um Medikamentendosis zu kontrollieren ist weitverbreitet und 
eine akzeptierte Methode in englisch und deutschsprachigen Ländern in Europa. Ein Drittel 
der Befragten benützen medizinische Apps während der Kinderreanimation. Diese 
Entwicklungen müssen sich in den lokalen und nationalen Richtlinien zur Benutzung dieser 
Technologie wiederspiegeln. Entwickler von Apps müssen wissen welche Mobilgerätetypen 
am meisten genutzt werden. Zulassungsstellen von medizinischen Apps müssen 
sicherstellen, das diese unabhängig von Geräte- und Herstellertyp benützt werden können. 
Seit der Entwicklung dieser Technologie 2008, haben Mobilgeräte und medizinische Apps 
neue Herausforderung und Möglichkeiten geschaffen, um die Patientenversorgung zu 
verbessern. 
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2 Abstract 
 
2.1 Introduction 
The use of mobile devices (smartphones and tablets) and apps is widespread in the general 
population. The use of these devices allows on-the-go access to information ranging from 
internet, apps and email like never before. The use of this technology as part of patient care 
is common among junior medical staff in the UK. In healthcare the use of mobile devices 
and medical apps has been shown to be a positive development in improving patient care. 
This revolution started with the release of Apple’s iPhone in 2007 signalling the birth of the 
smartphone. The next pivotal step was the launch of the Apple Appstore in 2008. This 
allowed users to download specific software applications “apps” from an online shop and 
other companies soon followed with their own offerings.  
2.2 Aims 
Currently little is known how this advance in technology is applied to emergency care. The 
aim of this work was to investigate the current role of mobile device and medical apps in 
emergency care in English and German speaking countries in Europe and to provide an 
overview of how departments and individual clinicians engage with this technology as part 
of their daily work. 
2.3 Method 
A web-based self-report survey (www.surveymonkey.com) was performed. The first part of 
the survey investigated departmental practise and was distributed via the PERUKI network. 
The second part of the survey looked at individual clinicians’ practise and was distribute via 
various channels including the RCEM newsletter, the RCEM website, the PERUKI network 
and social media. A German language version of the individual clinician survey was 
distributed via AAEMÖNK, DIGNA, ÖNK and SGNOR. 
2.4 Results 
Neither parts of the survey reported any harm from medical app use. Apple devices 
accounted for the majority (70%) of institutional mobile devices in the PERUKI network site 
survey. Apple devices were the leading device choice for individual clinicians too. In the site 
survey most sites provided between one to five medical apps on the institutional mobile 
device, similarly most individual clinicians had between one to five medical apps on their 
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personal mobile device. The leading five medical app categories were: medical reference 
app, compendium, microbial guidance, resuscitation and medical calculator app. The 
BNF/BNFc formulary app was the leading provided and recommended medical app in the 
site survey. In the individual clinician survey this was also the leading medical app on 
individuals’ personal mobile devices and the most recommended medical app. The use of 
medical apps was up to personal clinician choice in both surveys. 
2.5 Discussion 
Whilst no harm has been reported from this technology in our survey, this does not exclude 
the potential for harm. Registration of medical apps as medical devices with for example the 
MHRA is one way to monitor for harm.  
Apple was the leading hardware producer in all survey. The most likely reason for this is that 
Apple has been historically between the market leader. As in previous surveys there are 
generally no more than five medical apps installed per mobile device. This probably reflects 
that the following five medical apps types: medical reference, formulary, antibiotic 
reference, resuscitation and medical calculator app are the most useful in emergency care.  
The BNF/BNFc formulary app was the most common installed and recommended app in 
both surveys. This is also reflected in that nearly half of the individual clinicians said that 
they use their mobile device daily to check a drug dose. Around a third of individual 
clinicians and a third of sites use medical apps during paediatric resuscitation. All of this 
points to a greater role of medical apps in emergency care when compared to 2008, when 
none of this technology existed. 
2.6 Conclusion 
In the surveyed population in English and German speaking countries in Europe, the use of a 
personal mobile device to check drug doses is widespread. This is also reflected in that the 
BNF/BNFc formulary app was the leading app installed on mobile devices. A third of 
respondents use medical apps during paediatric resuscitation. This change in practise needs 
to be reflected in national and institutional policy. 
Developers need to be aware of the most commonly used devices. Equally when being 
licensed, bodies must ensure apps can be accessed equitably by all clinicians independent of 
device.  
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In summary since the launch of this technology in 2008, mobile device and medical apps use 
in healthcare has resulted in new challenges and opportunities to improve patient care.  
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3 Introduction 
 
An app, derived from application is a software program that can be run on any hardware 
platform (1). It is a term used for programs, which run on mobile devices for example 
smartphones or tablets. Medical apps are specific software programs used in healthcare 
ranging from formulary and reference apps to medical calculators.  
The use of mobile device technology is currently an expanding field in emergency care, it is 
therefore important to know how institutions and clinicians use mobile devices, mobile 
device functions and apps as part of patient care. A previous study of junior medical staff 
and medical students showed, that they commonly use smartphones and apps as part of 
patient care in the United Kingdome (2). In healthcare the use of this technology has been 
shown to be a positive development, improving patient care by allowing immediate access 
to medical and health care information, improving decision making, potentially reducing the 
number of medical errors, and enhancing telemedicine capabilities (3-6).  
The ever-evolving mobile device technology has resulted in an unrivalled ability to access 
and disseminate up-to-date information at exceptional speed across a chosen population. 
New apps are relatively easy to produce and release and allow rapid development and 
adaptation. A myriad of apps relevant to healthcare professionals are available from online 
stores, ranging from specialist communication apps, formularies, clinical decision tools and 
aids, guidelines and textbooks. 
As an example previous work from the USA showed, that the App Store's "Medical" 
Category  contains about 20000 apps, of these only about  6.9%  were clinically relevant. 
This is just under 0.1% of the overall App Store offerings (7). This shows that with multiple 
offerings it can be tricky for clinicians to find the right app on the App store. However even 
if one has found an app, they may not be able to install it on their device, as not all apps are 
available both as the Apple IOS and Android apps. Mobile device choice will influence what 
app they can install on their device. It is therefore important to know which apps clinicians 
have currently installed on their mobile device, which are their favourite ones and, which 
they would recommend to others 
Apps like any other reference aid developed in one setting may not work in another, 
because of differences in disease patterns and international, national and regional policy, 
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similar to any guideline or guidance applied blindly. It is therefore important to know which 
apps clinicians actually use. 
 
The rapid and organic growth of this new technology can result in new concerns and 
challenges. For example, patient’s personal information being exposed to online attacks and 
lack of quality control. The use apps and mobile technology might also be in conflict with 
existing institutional and healthcare policies and guidelines, restricting the use of mobile 
devices at the bedside. Clear guidance how to use this technology is key to protect the 
patient’s personal information, confidentiality and to protect users, i.e. clinicians from 
litigation. At the same time it is important to monitor for harm caused by the use of this 
technology similar to the introduction of any other new medical device or advance in 
therapy. 
 
An area where medical apps may be highly beneficial is in prescribing, especially paediatric 
prescribing. Medication errors are more likely to harm children than adults (11). This also 
reflected in that the BNF/BNFc formulary app is the most popular medical app in the UK (8-
10). Studies looking at simulated paediatric resuscitation at major paediatric teaching 
hospitals have found that medication errors commonly occur during all stages of paediatric 
resuscitation. In one study, only analysing syringe content identified these errors, suggesting 
that such errors, may be a major unrecognised source of morbidity and mortality during 
resuscitation in children (12, 13).  
Trials of simulated paediatric resuscitation have shown that the use of reference books and 
charts, providing weight-based pre-calculated doses all decreases drug dose errors, 
especially 10-fold errors, which could be potentially fatal for a child (14). 
The newest development are resuscitation aids are resuscitation apps which include the 
Mersey Burns (5), NeoMate (15) and PaediatricEmergencies (16) app. The use of the 
PaediatricEmergencies related PICU calculator app has been shown to be superior in 
paediatric inotrope prescribing compared to using the BNFc hardcopy, with even medical 
students outperforming paediatric consultants (3).  
The rarity of cardiac arrests in children, weigh-based prescribing, unfamiliarity with the 
equipment and guidelines, all add to increased cognitive load during the management of 
critical unwell children. The more complex and non-automatic a process is, the greater the 
 3-13 
cognitive load. Increased cognitive load leads to an increased potential for error and 
inaccuracy, and decreased retention of skills (17, 18). These factors can adversely affect 
both outcome for the patient and learning for the clinician. Mobile device and medical apps 
may decrease cognitive load by decreasing the need to perform complex calculations during 
paediatric resuscitation, prescribing, and making up infusions. This could be quantified in 
the time it takes to get the medication prescribed and made up, and also by analysing 
syringe content to ensure the actual right concentration is given (3, 12, 14) . 
 
Currently no study has addressed the use of mobile devices and apps as part of emergency 
care in paediatric and adults, nor described their benefits and potential risks. Nor has any 
study addressed, which aids are commonly used in prescribing and resuscitation. 
To guide best adaptation of this potentially beneficial technology, more knowledge about 
how clinicians use apps and mobile devices as part of patient care is essential.  
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4 Aim 
 
The use of mobile devices and apps is widespread and has the potential to significantly 
improve patient care. A better understanding of usage patterns is required to ensure these 
technology advances are embraced in the best possible manner. To achieve this, the aims of 
this study are: 
 
1) Explore risks or harm that has been observed from these technologies. As with any 
change or evolution in practice it is important to monitor for harm. The aim is to 
investigate if any harm has a resulted from the use of mobile devices and medical 
apps and to explore any other risks that may have arisen from the use of technology.  
 
2) Assess current policies on apps and mobile devices and how they affect use at the 
bedside. A review of the literature has revealed that there are possible 
inconsistencies between policies and actual use by clinicians. Departmental and 
institutional policies are key in shaping and supporting any change in healthcare. The 
aim is to explore existing guidelines and guidance for app usage as well as usage 
patterns and to provide insight of how apps can be best used in healthcare. Equally 
we are investigating the main barriers and enablers in the adaption of this 
technology especially from a departmental view focusing on the infrastructure 
provision to run the devices and the provision of apps by the institution. 
 
3) Assess how technology is used in emergency care. The aim is to gain better 
understanding how both departments and individual clinician use mobile devices 
and medical apps as part of emergency care. As the use of medical apps is currently 
and expanding field, we want to know how clinicians are actually using their mobile 
device and apps in their day to day practise in emergency care, as this may have an 
influence on patient management decisions and patient safety. 
 
4) Create an overview of the which mobile devices and apps are recommended and 
actually used. The aim is to explore which mobile device and which medical apps 
clinicians actually use and are provided or recommended by the different 
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departments. Different mobile device platforms e.g. Apple IOS and Android only 
allow the installation of apps specific to their platform. Not all apps are available to 
run on both platforms. We therefore want to know which mobile device clinicians 
and institutions use as this may influence the apps choice and use of this technology.  
Previous work has shown that it can be difficult for individual clinicians to find 
relevant medical apps, we therefore want to provide a current overview of the 
commonly used and recommended medical apps. Certain hospitals and 
organizations have commissioned and developed medical apps. We want to 
investigate this process further. 
 
5) Investigate the practical application of mobile device technology in prescribing and 
resuscitation. The literature has shown that the BNF/BNFc app has been the 
favourite medical apps used by clinicians in the UK (8, 19). We want to explore how 
apps are used prescribing in comparison to more traditional aids e.g. hardcopy 
formulary books. There always has been an abundance of use different aids in 
paediatric resuscitation ranging from the use of the WETFLAG calculation, Excel Crib 
sheets, etc. to the Broselow tape. We want to compare the advance in technology 
with these more traditional aids in both adult and paediatric resuscitation. This will 
also provide us with an indication of how widely this technology is used in our 
setting. At the same time, this will give us an indication in which areas of prescribing 
and resuscitation this advance in technology might be helpful and highlight any 
differences between adult and paediatric practice.  
 
To achieve this, a two-stage survey will be performed: 
(a) A stage (i) site survey of the PERUKI network sites to establish current departmental 
practice 
(b) A stage (ii) individual clinician survey to assess how individual clinician use this 
technology in everyday clinical practice. 
The two-stage survey approach will allow us to compare departmental with individual 
clinician practice. 
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5 Method 
To investigate the use of mobile devices and medical apps in emergency care both from a 
departmental and individual clinician perspective a two stage survey was performed in 
2017. The stage (i) survey investigated departmental practise. The stage (ii) survey 
investigated individual clinician practise. The surveys consisted of multiple choice questions 
and open textboxes allowed respondents to discuss any further issues (see appendix 3). 
The surveys were designed by the lead researcher and developed from previous literature 
examining mobile device and medical app use by clinicians and medical students (2, 6, 20). 
An expert panel reviewed the questions for content, validity, and reliability. A pilot survey 
was undertaken at one PERUKI site. Refinements were made during multiple iterations, with 
input from the study team and the PERUKI Research Steering Committee, before arriving at 
the final version. The two surveys were performed using a web-based survey platform 
(www.surveymonkey.com). 
 
5.1 Stage (i) site survey 
This survey investigated departmental practise at the PERUKI sites. The survey was 
disseminated via the PERUKI research network to all 54 PERUKI centres. At each PERUKI site, 
the site lead investigator (typically a consultant (attending) in Paediatric Emergency 
Medicine) was asked to complete a web-based self-report questionnaire. The PERUKI survey 
was open from the 31/07/2017 to the 02/09/2017. 
Data was collected in the following areas: basic demographic data of respondents, mobile 
device policy and infrastructure (Harm, mobile device policy and guidance, free Wi-Fi access, 
barriers and enablers to medical app use, institutional mobile device provision and medical 
app provision, medical app provision on institutional device, institutional recommended 
medical apps to download, designed and commissioned apps, prescribing and resuscitation 
in children and adults). A copy of the survey is provided in Appendix 3. 
 
5.2 Stage (ii) individual clinician survey 
This survey explores individual clinician practise. The survey was displayed on the RCEM 
website, shared in the RCEM newsletter and via the co-collaborators twitter feeds. It was 
also disseminated to all 54 PERUKI site lead investigators, asking them to distribute the 
survey to their staff (medical and allied health professionals) to complete. The survey was 
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open from the 17/07/2017 to the 14/01/2018 (displayed on RCEM website from the 
17/07/2017 until the 17/12/2017). The German language version of the survey was 
distributed via DGINA, AAEM, ÖNK and SGNOR for their members to complete. The German 
language survey was open from the 08/10/2017 to the 21/01/2018. Data was collected in 
the following areas: basic demographic data of respondents, mobile device policy and 
infrastructure (harm, wi-fi provision, mobile device type, number of medical apps on 
personal device, device policy, mobile device use in the clinical setting, type of medical apps, 
prescribing and resuscitation in children and adults). A copy of the survey is provided in 
Appendix 3.  
 
5.3 Analysis  
Both Excel and Surveymonkey were used to analyse the numerical data. Descriptive statics 
were used to describe the data. Answers from open ended questions were analysed using 
excel for single word answers e.g. name of an app. The author also performed semantic 
coding and organised the remaining responses to the open-ended questions. Quotations are 
used to illustrate the key themes from these responses. 
 
5.4 Ethics 
Both surveys accessed clinicians via a research collaborative to assess their departmental 
and personal practice. According to the Framework for Health and Social Care Research (UK) 
(21) both surveys did not require formal ethics review. Consent was implied by 
participation. 
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6 Results  
 
6.1 Stage (i) site survey 
 
The study questionnaire was sent to all 54 PERUKI site lead investigators (consultant in 
paediatric emergency medicine) to complete on behalf of each site. 46 sites completed the 
survey (completion rate 85.1%). Demographics are listed in table 1.  
  
 Stage (i) site survey: Harm  
No site reported any harm from medical apps use, 
 
 Stage (i) site survey: Mobile device policy and Guidance  
Out of the 46 responding sites, 24 reported that they have a mobile device policy covering 
both personal and institutional mobile device use in the clinical environment and at the 
bedside. The other 22 sites did not have mobile device policy.  
Of the 24 sites with a device policy, 23 provided further details regarding the use of a 
personal mobile device at the bedside. At 13 sites it was allowed to use a personal mobile 
device in the clinical environment.  At the other 10 sites it was not allowed. However the 
ban was only enforced at 4 of these sites and at the remaining 6 sites the use of mobile 
devices was tolerated in the clinical environment, despite being officially banned according 
to their mobile device policy. 
At the 24 sites with a mobile device policy, the use of an institutional mobile device in the 
clinical environment was allowed at 22 sites. At the remaining two sites the use of 
institutional mobile devices in the clinical environment was banned. However these two 
sites provided an institutional mobile devices and their use in the clinical environment was 
tolerated.  
Out of the 24 sites with a mobile device policy only 6 sites provide guidance on mobile 
device use, i.e. how the mobile device and medical apps should be used by clinicians as part 
of patient care. The responses which show a high variation are listed in table 2 and mainly 
centres around the promotion of institutional apps and device functions. 
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 Stage (i) site survey: Free Wi-Fi Access 
Free Wi-Fi access is provided at 31 sites. Limited Wi-Fi (e.g. patient Wi-Fi, university Wi-Fi, 
limited bandwidth, hospital at night team only) is provided at 6 sites. 9 sites did not provide 
any free Wi-Fi for their staff.  
12 sites (39%) that provide free Wi-Fi, have a mobile device policy that allows the use of 
personal mobile devices at the bedside. 
 
 Stage (i) site survey: Barriers and enablers to medical app use 
Table 3 lists barriers and enablers that have influenced the up-take of medical apps at these 
sites. The 17 “other” responses are listed at the bottom of table 3. 
 
 Stage (i) site survey: Institutional Mobile Device Provision and Medical App Provision  
37 sites provided information regarding the provision of institutional mobile device to run 
medical apps. Mobile devices are provided at 19 sites. Some sites offer more than one 
device or a choice of devices. Apple iOS devices accounted for 70%, Android 23%, and 
Blackberry for 7% of the provided institutional devices, as shown in Figure 1.  
At these 19 sites 9 sites provided no medical apps, 9 sites provided 1-5 medical apps and 1 
site provided more than 6 medical apps on the institutional mobile devices.  
 
 Stage (i) site survey: Medical app provision on institutional device and institutional 
recommended medical apps to download 
Table 4 lists the actual names and types of the medical apps provided on the institutional 
mobile devices. 20 sites recommended specific medical apps to download. One sited 
provides training with regards to medical apps by covering their use as part of 
professionalism during induction.  
When interpreting table 4 it is important to keep in mind that recommended apps may be 
available for both apple and android platforms even if they are only listed for one. 
The BNF/BNFc app is the most commonly available medical app on the institutional devices. 
The most common type of app available on institutional device were medical reference 
apps, but there is no clear preference for a certain app.  
The most recommended medical app is the BNF/BNFc app followed by the RxGuidelines 
app, the Induction app, and the Microguide app. The Microguide, RxGuidelines, and 
 6-20 
Induction app are all apps that can be configurated to local guidelines. For example, in the 
Microguide app the local antibiotic guidelines has to be selected prior to use. This also 
multiple institution to use the same interface, whilst providing local guidance and allowing 
local configuration of theses through the respective microbiology department. 
 
A diverse number of medical reference apps accounted for the majority of recommended 
apps. This was then followed by a number of formulary and antibiotic guidance apps. The 
majority of these apps are regional specific as for example the Antimicrobial NHS Scotland 
app or the Microguide app with the local configurations 
 
 Stage (i) site survey: Designed and commissioned Apps  
17 sites had designed medical apps. In-house clinicians designed those at 4 sites, clinician 
together with the in-house IT department at 4 sites, and an external IT company at 3 sites. 6 
sites did not know who designed their apps. Designed and commissioned apps are listed in 
Table 4 lists by type and name. The majority of the designed and commissioned apps are 
local reference app.  
 
6.2 Stage (ii) individual clinician survey 
 
In total 450 individuals responded to the survey. The demographics of the respondents are 
listed in table 5. Whilst the majority of respondents were from the UK, Ireland, Austria, 
Germany and Switzerland, there were also some respondents from other countries as listed 
in table 5. 
 
 Stage (ii) individual clinician survey: Harm  
None of the respondents reported any harm from the use of medical apps in this survey. 
 
 Stage (ii) individual clinician survey: Wi-Fi provision  
In the surveyed population 65.7% of respondents are provided with free Wi-Fi access at 
work, whereas 29.3% had no Wi-Fi access and 5% limited Wi-Fi access (e.g. patient and 
visitor Wi-Fi, EDUROAM Wi-Fi, limited bandwidth). 
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 Stage (ii) individual clinician survey: Device type  
The type of the personal mobile device respondents use is listed in table 6. 
 
 Stage (ii) individual clinician survey: Number of Medical Apps on Personal Device  
The number of medical apps on the personal mobile device are listed in table 7. 
 
 Stage (ii) individual clinician survey: Institutional Mobile Device Policy  
380 of the 450 respondents completed questions regarding institutional mobile device 
policy. 41.6% were not aware of their mobile device policy at work.  
Of the other 58.4% of individuals who were aware of their institutional device policy, 52.4% 
were allowed to use their personal mobile device in the clinical environment at the bedside, 
35.7% were not allowed (however their use was tolerated in 78.4% of cases) and 11.8% did 
not know.  
Of the 58.4% of individuals who were aware of their institutional device policy, 59.1% were 
allowed to use their institutional device in the clinical environment, 12.7% were not allowed 
(however tolerated in 46.4% of cases) and 28.2% did not know. 
 
 Stage (ii) individual clinician survey: mobile device use in the clinical setting  
Individuals personal mobile device type use in the clinical setting is listed in table 8. 
 
 Stage (ii) individual clinician survey: Type of Medical Apps  
The medical apps on personal mobile device of the individual respondents are listed in table 
9. Apps providing similar functions were grouped together to provide an overview in table 9. 
Table 10 lists the personal favourite medical apps on personal device of the individual 
respondents. Table 11 lists the medical apps provided on institutional device individual 
clinicians have access to (e.g. iPad in resus) and Table 12 lists the medical apps that 
individuals recommend. 
 
6.3 Comparison of Prescribing and Resuscitation in Children and Adults in the site (i) 
and departmental (ii) survey 
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Table 13 and table 14 list the difference in prescribing practices and in the use of 
resuscitation aids between children and adults in both surveys   
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7 Discussion 
A two staged survey was performed to provide a snapshot of mobile devices and medical 
apps provision, and their use in emergency care both from a departmental and individual 
clinician point of view in stand-alone paediatric, mixed and adult only emergency 
departments mainly in English and German speaking countries in Europe.  
 
7.1 General demographic info 
The stage (i) site survey was completed by a consultant (attending physician) at each PERUKI 
network site (22). This combined with the high response gives us every confidence that the 
survey reflects current practise at through the UK and Ireland. The combination of pure 
paediatric emergency departments and mixed departments treating both adults and 
children in the network ensures that the survey reflects current practise across the UK and 
Ireland. 
With regards to the stage (ii) individual clinician survey, we had no influence who would 
complete the survey. The majority of respondents were consultants (attending physicians). 
This gives us every confidence that this survey reflects current practise.  
 
7.2 Harm 
None of our surveys reports any harm as a result from medical app use. One consideration 
when adapting any new medical device or treatment is the potential for harm. Most medical 
apps are not licensed as Medicines and Healthcare products Regulatory Agency (MHRA) 
approved devices and therefore any harm may not be reported. One of the first medical 
apps to gain MHRA approval was the Mersey Burns app (5). Whilst this technology appears 
safe so far, vigilance is key to detect and report any harm, especially as this technology 
becomes more widespread. Developers should aim for MHRA registration as a seal of 
approval as is already the case for the Mersey Burns app (5) and NeoMate app. This would 
reassure both patients and clinicians. 
 
7.3 Mobile device policy and Guidelines for medical app use 
In the stage (i) site survey less than half of all the responding departments had a mobile 
device policy covering either the use of a personal or institutional mobile device at the 
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bedside. Nearly half of the individual clinicians in the stage (ii) individual clinician survey 
were not aware of their institutions mobile device policy. In both surveys, sites that ban the 
use of mobile devices generally do not enforced it. This questions the reason for the ban in 
the first place, especially when it is not enforced. As highlighted by one site where they had 
to put up signs explaining that staff are using mobile devices for patient care. Especially with 
the increasing digitalisation of healthcare, there is an urgent need for a consistent and 
evidence-based approach across health services with regards to mobile device and app use. 
In the stage (i) site survey only a minority of sites provide any guidance regarding medical 
app use. Any guidance mainly focused on the promotion of institutional specific apps and 
the BNF/BNFc App (23).  
Our surveys show a distinct lack of knowledge and implementation of national policy and 
guidance from a UK perspective (24, 25).  NHS digital guidance, last updated in November 
2018, provides specific guidelines on the use of mobile devices in various settings within 
NHS hospitals (see Appendix 4). 
This is in stark contrast with the reported widespread adaptation of this technology in the 
clinical environment (19, 26-28). Following the completion of this survey, the National 
Trauma Network in the UK approved Whatsapp as an official communications app on the 
16th February 2018 in line with NHS Digital guidance (26) as response to the mass casualty 
events that took place in the UK in 2017. This demonstrates the rapid evolution and 
adaptation of this technology in healthcare and the need for a standardised approach with 
respect to its use. 
 
7.4 Wi-Fi provision 
Wi-Fi is an important aspect of mobile device technology allowing connection to the 
internet, sharing and accessing information on the-go. Whilst not all of the mobile device 
functions or medical apps need a constant connection to work, Wi-Fi provision was found to 
be a key enabler in the stage (i) site survey for the adoption of this technology. In both 
surveys, only about two-thirds of all institutions provided a free and usable Wi-Fi 
connection. The provision of free and stable Wi-Fi connection should be strongly considered 
to aid this digital revolution. The institution not providing free quality Wi-Fi should address 
this as a key priority. From a UK perspective the NHS Digital Strategy recommends the 
 7-25 
provision of free Wi-Fi at all sites (24) that was last updated in November 2018. Equally a 
substantial proportion of sites in the site (i) survey that provide a free Wi-Fi connection have 
a progressive mobile device policy, i.e. allowing the use of a mobile device at the bedside. 
This may reflect that free Wi-Fi provision is also a marker of embracing this technological 
revolution and sign of digital literacy of that department. 
 
7.5 Barriers and enablers to this technology 
In the stage (i) site survey, poor Internet and Wi-Fi connection was perceived as the main 
barrier to the use of this technology. This might be explained by the fact that if there is no 
internet connection, individuals do not use their mobile device for their usual functions (e.g. 
email and social media access) resulting in an overall decreased app use. Also all mobile 
devices need to be connected to the internet to install and update the installed medical 
apps and in the case of certain medical reference apps to run them, therefore the lack of 
Wi-Fi leads to poor technological literacy in that department.  
 
Funding is commented on as a further barrier to the adaption of this technology. For 
example one site uses a charity donated iPad to run a resuscitation medical app in resus. 
Increased funding may allow increased provision of hardware, i.e. mobile devices in the 
departments. It may also allow the provision of a range of medical apps that can be 
provided for free to the staff to run on their personal mobile device. Previous surveys have 
shown that clinicians are willing to use their personal mobile device and medical apps that 
they have purchased themselves or are provided for free as part of patient care (29).  
 
Colleagues were identified as the leading enabler in the adaption of this technological 
revolution. Positive peer pressure may be one explanation for this (29). Good internet (Wi-
Fi) connection, the institution and the provision of free medical apps were reported as key 
enablers of medical app use. These enablers are reflected in the NHS Digital strategy for 
universal Wi-Fi provision and in the NHS digital mobile device guidance (24, 25) that was last 
updated in November 2018. 
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Patients were seen equally as barrier or enabler to medical app use. This is consistent with 
the iDoc project in Wales (7, 19, 30), which provides foundation year doctors access to three 
medical textbooks and the BNF/BNFc app on their smartphone for free. It anticipated and 
identified patients as one of the potential challenges for the project. They proposed the 
following three scenarios that might be encountered by junior doctors at the bedside: “you 
should know this by now”, “using social media apps and playing games” and “especially 
elderly patients can see it negatively, at the bedside, we need sensitivity” (7, 19, 30).  
These concerns are also reflected in the comments from one institution in stage (i) site 
survey, “had to put up signs to tell patients that some staff use phones for taking 
observations, looking up information, etc”. Explaining, informing and including patients in 
this digital revolution is key to ensure patient acceptability. 
 
The most common comment in the “other” category is that medical app use, is up to 
individual clinician choice. This may reflect that we are still in the organic growth phase of 
the current digital revolution. The creation of a positive environment will increase the use 
and acceptability of this advance in technology as envisaged by the NHS digital strategy (24, 
25).  
 
7.6 Use of mobile device technology by individual clinicians 
The stage (ii) individual clinician survey the main use of mobile device technology was for 
web-access, followed by email, rota/calendar and social media access by individual 
clinicians. The stage (ii) individual clinician survey shows that we are at a threshold of this 
digital revolution with nearly half of the respondents using this technology as part of daily 
patient management (formularies, medical calculators and scoring systems, and disease 
diagnosis and management) compared to 2008 when this technology did not exit. These 
changes in how we access information and manage patients, needs to be reflected in 
national and institutional policy and guidance (24, 25). 
 
7.7 Mobile device type 
In the stage (i) site survey only a minority of sites provided mobile devices for staff to use. 
This included a charity donated iPad in resus to run a resuscitation medical app at one site. 
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The reason for this is that in the UK institutional mobile devices are generally only provided 
for consultants (attending physicians) explaining the low number of institutional devices. 
In the stage (i) site survey Apple devices were the most common provided type of 
institutional mobile device followed by Android devices. In the stage (ii) individual clinician 
survey Apple devices accounted for just over two-thirds of the devices and Android for the 
nearly all the remaining devices. Previous studies have shown the preference for Apple 
devices by medical staff (31-33). Apple has historically been the market-leader, both in the 
mobile device market and by being the first company to have an App store allowing 
developers to sell, and consumers to purchase and download apps (34, 35). Previous 
surveys have reported that medical doctors are happy to use their personal mobile devices 
as part of patient care (5, 10).  
Based on our data on device availability, usage, and previous surveys in the UK, medical 
apps should be compatible with iOS and Apple products, as there are the most common 
mobile devices and operating systems. To achieve widespread uptake, apps should also be 
compatible with android products.  
 
7.8 Medical App per Mobile Device 
Previous surveys from junior doctors and medical students have shown that they have 
between one to five medical apps installed on their smartphone (19). This is also reflected in 
both surveys where between one to five medical apps were provided on the institutional 
mobile device or the individual clinician had between one to five medical apps on their 
personal device. One explanation could be that most clinicians have up to five medical app 
corresponding to each of the leading medical app categories on their mobile device. In both 
surveys the five leading medical app categories included medical reference, formulary, 
resuscitation, medical calculator apps and antibiotic guideline apps. 
 
7.9 Medical apps  
Previous studies have shown that it is difficult for clinicians to find the medical apps on the 
app store. Apps providing similar functions were grouped together to get an overview of the 
most common used apps in our survey. In both the stage (i) and stage (ii) survey the leading 
five medical app categories installed on either the institutional or personal mobile device 
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were medical reference, formulary, resuscitation, medical calculator apps, antibiotic 
guideline, and a number of various miscellaneous apps.  
UK clinicians have consistently reported that the BNF/BNFc formulary app is their favourite 
medical app (8, 30). This was also confirmed in our surveys. The BNF/BNFc formulary app is 
aimed at prescribers, pharmacists and other healthcare professionals, who need up-to-date 
information about medicines. The app was developed to present the BNF/BNFc content in a 
more digital-ready focus, in line with the NHS digital strategy. The advantage of presenting 
this information as an app is that the content can easily be updated in timely manner 
compared to the annual edition of the paper copy and allows rapid transmission of any 
changes to clinicians. The app is currently available for free for all UK users (23). This may be 
especially relevant to paediatric prescribing where the RCPCH has identified prescribing as 
an area of difficulty. Access to the BNF/BNFc formulary app at the bedside can aid safe 
prescribing (5).  
In the stage (ii) individual clinician survey the leading medical reference apps were uptodate 
and Medscape medical apps, which are based on North American guidelines. Microguide 
was the leading antibiotic guideline app. For a department it is important to be aware, 
which medical apps staff consult, as this may influence management decisions and how 
medications are dispensed. Similar to consulting a textbook and depending on the incidence 
and prevalence of a specific condition, this may lead to over or under investigations and 
potentially inadequate treatment. This is especially important with empirical antibiotic 
therapy, that should reflect local resistance and sensitivity patterns.  
There is a trend to use medical apps that can be configured to local guidelines, especially 
with antibiotic guideline apps. The stage (i) and stage (ii) survey identified the following: 
RxGuidelines, Induction, Microguide apps that can be configurated to local guidelines. 
The leading installed resuscitation medical apps in the stage (ii) individual clinician survey 
were iResus, PaediatricEmergencies and NeoMate. In the stage (ii) individual clinician survey 
the PaediatricEmergencies app was the leading favourite and recommended resuscitation 
medical app on both the institutional and personal mobile device in all settings. One 
explanation for this could be that PaediatricEmergencies app not only provides the 
resuscitation algorithm, but also calculates the drug dose, provides information on how to 
make up the drug or infusion, and how to administer it near instantaneously. An advantage 
of using apps in this setting has also been demonstrated in a study of paediatric inotrope 
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prescribing, where the PaediatricEmergencies app related PICU calculator app was shown to 
be superior in paediatric inotrope prescribing compared to using the BNF/BNFc hardcopy 
formulary, with medical students outperforming consultant paediatricians (3).  
 
The multiple offering of similar apps within one medical app category, may be explained 
that we are still in the organic growth phase of this digital revolution. As previously 
highlighted, medical apps used by clinicians should be ideally registered by MHRA or similar 
regulator as a medical device. Local or national regulators or Royal Colleges should consider 
licensing or approving medical apps in each of the main app categories to provide clinicians 
with a choice of apps that they can rely on, and that is specific to the setting. Part of this 
process should also ensure that apps and the information is kept up to date, which could be 
achieved through MHRA registration.  Local or national regulators, or royal colleges should 
consider the commissioning of medical apps in each of the leading categories relevant to 
their specific needs.  
 
7.10 Medical app design and commissioning process in the PERUKI network 
Survey (i) identified a good example of how medical app development is embraced at one 
site, where they organise regular hackathons to develop medical apps. The majority of sites 
that have developed apps, did so with the input from either internal or external IT 
departments. Having access to clinicians who are trained in app develop and who are able 
to support this process is key to future development. The absence of good IT support was 
raised as a concern at 9 sites. This raises the question, if basic IT and app development skills 
should be included as part of the training of the next generation of clinicians moving on 
from just providing apps for clinicians to use (30) or if this needs to be part of a wider 
national or international development strategy. As previously highlighted developers need 
to be aware of the commonly used device types, used by both institutions and individual 
clinicians, as identified in our survey, to be able to provide compatible software. 
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7.11 Practical Application of Mobile and App Technology in Emergency Care: 
Prescribing and Resuscitation 
Previous studies have shown that formulary apps are the most popular and widely used app 
category by clinicians. The use of apps in prescribing and resuscitation is used to show case 
how this advance in technology is applied by departments and clinicians as part of direct 
patient care. 
Previous research has shown that children are more likely to be harmed than adults by 
medication errors (36-38). Emergency departments can be stressful and distracting 
environments potentially leading to increased cognitive load and errors. The RCPCH has 
therefore developed specific training and recommendations for safe prescribing in 
paediatrics. In paediatrics it is standard practice to double check doses in the formulary and 
dose calculations when dispensing medication and making up infusions. The 
recommendations include having a specific prescribing area, where medical staff is not 
disturbed when calculating, prescribing, checking and making up medications and infusions 
to decrease medication errors (37).  
The rarity of cardiac arrests in children, weigh-based prescribing, unfamiliarity with the 
equipment and guidelines can all add to increased cognitive load during the management of 
critical unwell children. (17, 18). Studies looking at simulated paediatric resuscitation at 
major paediatric teaching hospitals found that medication errors occur during all stages of 
paediatric resuscitation. In one study, only analysing syringe content identified these errors, 
suggesting that such errors may be a major unrecognised source of morbidity and mortality 
during resuscitation in children (12, 13).  
This has led to the development of a variety of prescribing and resuscitation aids (APLS 
WETFLAG calculation, the Broselow Tape, a variety of Crib sheets and medical apps) (9, 14, 
39, 40). Previous studies looking at simulated paediatric resuscitation, have shown that the 
use of reference books and charts providing weight-based pre-calculated doses all 
decreases drug dose errors, especially 10-fold errors, which could be potentially fatal for a 
child (14).  
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In this context apps, have the potential to decrease medication errors by providing 
medication doses and instructions of how to make up infusions at the fingertips of clinicians 
near instantaneously on the go.  
 Prescribing 
In the site (i) survey, the use of a formulary book (BNF/BNFc) was the leading way to check a 
medication dose as recommended by the RCPCH followed by the use of formulary apps (e.g. 
BNF/BNFc or equivalent). This was also the leading choice for individuals working in the UK 
and Ireland. This was not the case for the respondents in the German language survey. 
Using the local electronic guidelines on the desktop computer or a formulary app on the 
personal mobile device were the top two choices in the German language survey. This may 
reflects that in German speaking countries most of the prescribing is already part of 
electronic medical patient record, which have inbuild electronic formularies (41-43).  
In the stage (ii) individual clinician survey, the use of desktop computers to access electronic 
formularies was the most often selected “other” choice to check a drug dose. This may be 
explained by the fact that most institutions provide free access to electronic formularies via 
the institutional desktop computer.  
The BNF/BNFc app on the personal mobile device has been consistently chosen as the most 
popular medical app in a number of surveys in the UK by different groups of doctors (8, 30). 
Access to an electronic formulary on the personal mobile device or the desktop computer 
appears to be the future for checking medication and dosing regimens for clinicians (8, 30, 
44). At the same time having access to alternatives such as paper-based back-up are 
important, especially in case of electronic devices failure. 
 
 Resuscitation 
Resuscitation and the management of critically ill or injured patients is an integral part of 
emergency medicine. The general management of these patients follows standardised 
algorithms. Adult resuscitation account for vast majority of all resuscitations with children 
accounting for only 2% of all cardiac arrests in some cohorts (17, 18). In our stage (ii) 
individual clinician survey resuscitation from memory was much more common in adults 
than in paediatrics. Resuscitation from memory in adults had a higher response in German 
speaking countries compared to the responses from the UK and Ireland. One explanation 
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may be that the respondents from the German speaking group treat more adults. In both 
surveys, the stage (i) site and the stage (ii) individual clinician survey this was also reflected 
in the comments regarding adult resuscitation under “other”, which included: “we do this so 
often we know all doses from memory” and “ready-made syringes” (17, 45). The use of wall 
mounted resuscitation aids similar to Advance Life Support (ALS) algorithm was higher in 
German speaking countries compared to the UK and Ireland.  
The APLS WETFLAG calculation used to estimate the weight, endotracheal tube length, fluid 
bolus, lorazepam, adrenaline, glucose dose of a child, was the leading choice both in the 
stage (i) site and the stage (ii) individual clinician survey. The advantage of the APLS 
WETFLAG calculation is that equipment and medication doses can be pre-calculated and 
prepared in anticipation of the arrival of the child in resus based on the age of the child.   
 
There was no difference in the use of medical apps in paediatric resuscitation between UK 
and Ireland versus German speaking countries. One advantage of using medical apps is that 
some of them not only provide the dose, but also instructions on how to make up the 
medication, i.e. the dilution and how to give, i.e. as slow bolus, as an infusion, etc. nearly 
instantaneously (8, 14, 46). Knowing the correct dose in paediatric resuscitation is often 
only half the answer. One also needs to know how to dilute and give it. Previous work has 
shown that the use of PICU calculator app is more accurate and quicker than using the 
BNF/BNFc (3, 36) to make up inotrope infusions. Examples of these type of medical apps 
that provide this information include the Mersey Burns, NeoMate and 
PaediatricEmergencies apps (3, 5, 15, 47).  Whilst this survey suggests that there is may be 
an increasing prevalence of medical apps to aid preparation for paediatric resuscitation 
when compared to 10 years ago, when none of these apps existed, further work is needed 
to delineate their adaptation over time. 
The use of printed institutional weight and age-based resus Crip sheets for children was 
most common in PERUKI hospitals, less common in other UK & Ireland hospitals, and least 
common in German speaking countries surveyed. This difference might reflect that the 
majority of respondents from German speaking countries treat adults only.  
Examples of printed and validated resuscitation reference aids include the Paediatric 
Emergency Medication Book (14, 39, 48) and SPARC Cards (14, 39, 48). Other sources for 
drug doses are printed reference sheets from web-based paediatric resuscitation medicine 
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calculators that can be accessed via the desktop computer. The following web-based 
calculators hosted by regional paediatric retrieval services were recommended by 
respondents in our survey: CrashCall (49),  SCOTstar (50), STRS (4), and KIDS (51). The 
advantage of their use is that infusions are made up in accordance with the regional 
standard. This is especially helpful if the patient has to be transferred to centres of higher 
care. 
The use of the Broselow tape was overall rare in the surveyed population. The advantage of 
the Broselow tape is, that no calculations need to be made, as everything can be read of the 
tape, once the child is measured, therefore potentially reducing the chance of medication 
error as described in the literature  (36, 52-55).   
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8 Limitations 
The site (i) survey was conducted only at PERUKI sites in the UK and Ireland. Not all sites 
completed the survey. The sites that did not complete may not use mobile devices or 
medical apps, therefore potentially skewing the results in favour of the centres that have 
embraced this technology. A lead researcher completed the survey on behalf of their site. 
We assume that the PERUKI site leads entered the current practise for their site and not just 
their individual practises. The site (i) survey only provided general data and does not reflect 
the practise of individual healthcare professional at each site. This survey did not take any 
patient perspective into account. 
With regards to the stage (ii) individual clinician survey, this was distributed through 
different channels. We had no influence over who would respond to this survey. We assume 
that a range of participants responded and not only individuals that embrace this 
technology. Consultants (attending physicians) accounted for nearly two-thirds of all the 
doctors that responded and therefore this should reflect current practise. Previous studies 
have shown that medical app use is more wide-spread among junior doctors and medical 
students, therefore this survey may actually underreport medical app use (2).  
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9 Conclusion and Recommendations 
The survey suggests an increasing digitalisation and cultural shift from paper-based to 
electronic resources in prescribing and resuscitating over the last 10 years. The start was the 
launch of the App sore in 2008 and the subsequent development of medical apps since, e.g. 
the release of the first version of BNF/BNFc app in 2012. The use of mobile device 
technology in the study population is widespread with nearly half of the responding 
individuals accessing medication information on their personal mobile device daily.  
The aims of the survey were to provide an overview to the current use of mobile device 
technology and medical app use in emergency care. The focus was on the hard- and 
software used by institutions and individuals. Mobile device policy was a focus as this 
governs the use of this technology at the bedside. To illustrate the use of this technology in 
the clinical setting and the use this technology in prescribing and resuscitation was used. 
Previous work had highlighted that formulary apps are the most widespread type of medical 
apps used by UK clinicians (8, 10, 19). 
The organic growth of this advance in technology in our networks has led to a range of 
policies governing mobile device use as part of patient care ranging from prohibition at one 
end to encouraging the use specific apps at the others. Local teams as a response have 
developed their own apps to solve their specific needs e.g. local reference and triage app 
(POPS). This is also highlighted in the numerous offerings in certain app categories. 
This survey highlights the following steps are needed to improve the integration of mobile 
device technology and medical apps in our setting. From a UK perspective the stage (i) site 
survey shows a distinct lack of knowledge and a lack of implementation of the NHS Digital 
strategy and guidance regarding infrastructure, mobile device and medical app use in the 
PERUKI network (25). There is an urgent need to highlight these policies to all staff and 
patients, and to implement this strategy. Especially inconsistencies in policy, which ban the 
use of mobile device as part of direct patient care but are then not enforced, need to be 
addressed as this leaves institutions and individuals open to complaints and potential 
litigation.  
Colleagues and the provision of Wi-Fi were key enablers of this technology. The absence of 
Wi-Fi was one of the main barriers of this technology. There has to be a focus on providing 
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the hardware infrastructure, i.e. Wi-Fi to allow this technology to flourish and improve 
digital literacy. 
 
None of the responding sites or individuals reported any harm of associated from mobile 
device or medical app use. The use of this technology has been linked to improved patient 
care (5). It is important to have systems in place to report any issues with medical apps so 
that these can be addressed and do not lead to patient harm. MHRA registration may be 
one way to achieve this, as is already the case for some of the leading resuscitation medical 
apps e.g. MerseyBurns and NeoMate apps (5, 15). 
Previous work has shown that it can be tricky for clinicians to find the right app on the app 
store (16). In our survey, certain sites have taken steps to promote and encourage the use 
medical apps including locally designed medical apps at their site to encourage staff to use 
the most appropriate apps for their setting. 
There is duplication in the offerings in some of the medical app categories e.g. the different 
antibiotic guidance apps. There is already a move to standardise some of the apps, as is the 
case for the Microguide, RxGuideline and Induction app. This process may be advantageous 
and should be further investigated, whilst still respecting the need for local solutions. This 
process may be especially useful for rotating doctors, who are then already familiar with 
these apps. 
Prescribing and resuscitation, were used to illustrate the use of apps in clinical practice. 
Our survey and previous studies have shown that the BNF/BNFc app has the highest up-take 
among users in the UK (13), with nearly half of the individual respondents using a formulary 
app daily. This development should be encouraged. Medical staff should be provided with 
ready to access formularies at the bedside. The use of the BNF/BNFc app or equivalent on 
personal mobile device of the treating clinician would be an easy way to achieve this. This 
goes hand in hand with local policies that allow this.   
Our survey showed that there is already widespread use of apps during paediatric 
resuscitation. Whilst paediatric resuscitating may be perceived to be more complex, this 
does not have to be the case. The use of aids including apps has been shown to reduce 
cognitive load in simulated resuscitation scenarios. Further work is needed to demonstrate 
that the use of apps can decrease cognitive load and improve resuscitation and outcomes in 
the real world. 
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Access to paper-based back-up alternatives e.g. paper-based BNF/BNFc or similar formulary 
books and in resus the Paediatric Emergency Book or similar aids is a must, especially in case 
of electronic devices failure. 
 
Finally, thought should be given to IT and app development training for the current and next 
generation of clinicians, to help guide this digital revolution and improve digital literacy. 
Programs to increase the digital literacy and aid app development should be developed. 
Developers need to be aware of the most commonly used mobile devices. Equally when 
being licensed, bodies must ensure apps can be accessed equitably by all clinicians 
independent of device. 
 
This study has also identified a number areas for further research.  Future work should also 
explore both patient and health care staff acceptability of this technology as part of patient 
care at the bedside. Follow-up data is needed to see how this technology is actually 
perceived once implemented by both medical staff and patients and carers.  
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10 Appendix  
 
10.1 Appendix 1: Figures 
 
 Figure 1: site survey: Institutional mobile device type and device manufacturer  
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10.2 Appendix 2: Tables 
 
 Table 1: Stage (i) site survey: Demographics 
Total Sites  54 
Responding Sites 46 
Completion 85% 
Centres that treat only children 43% 
Centres that treat both adults and children 57% 
 
 Table 2: Stage (i) site survey: Guidelines for medical app use  
1. Some medical apps are encouraged (Alder Hey antibiotic guideline, BNFc and  
Burns app). The trust has a mobile device policy. No policy for medical apps even 
on trust owned mobile devices. There is a trust policy on social medial access and 
use which includes and is not limited to 'apps'. 
2. Written policy 
3. Very little guidance. 
4. For use for clinical reasons. 
5. No specific guidance. Trust has 3 internal apps for use by staff in the clinical area 
6. No multimedia messages via text message, committee has been set up to examine 
the use of “whatsapp”. This is currently happening regularly with anonymised 
pictures being sent between on-call teams 
 
 Table 3: Stage (i) site survey: Barriers and enablers to medical app use  
  Barriers  Enablers  
Colleagues Preventing use: 3  
7% 
Encouraging use: 20 
43% 
Institution Preventing use: 5 
9% 
Encouraging use: 11 
24% 
Patients Preventing use: 4  
9% 
Encouraging use: 4 
9% 
Technical 
issues 
Preventing use: 9  
20% 
Encouraging use: 6 
(13% 
Internet or 
Wi-FI 
connection   
Absence/Poor connection: 17  
37% 
Provision/Good connection: 19 
41% 
Purchase 
Price of App 
(Cost) 
High cost: 5  
9% 
free to download: 11 
24% 
Price to 
create App 
(Cost) 
High cost:  8  
17% 
Low cost or free: 2 
4% 
Other Other Barriers: 11 (24%) Other Enablers: 6 (13%) 
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Free text 
responses 
“Other” 
1. No barriers 
2. No real barriers 
3. Apps are simply used by 
individual clinicians on their 
personal phones using the 
national 4G network 
4. There is no mandated use of 
apps, it will vary for each 
individual 
5. Our department per se have 
not developed an app but are 
in collaboration with the wider 
trust and use 2 apps provided 
by the trust for clinical use. The 
other apps would be personally 
downloaded apps 
6. variable reliability, slow to 
update 
7. Slow update/ loss of 
connection due to poor Wi-Fi/ 
3G signal 
8. Trust issued android phones 
which act as bleeps, hospital 
Wi-Fi (free Wi-Fi and VIOP). 
The VOIP is much better than 
the free Wi-Fi, but patchy 
reception around the hospital. 
Installing apps via IT guy as 
need to pay for the app and 
Wi-Fi isn't good enough to 
download it.  
9. Have had to put up signs to tell 
patients that some staff use 
phones for taking observations, 
looking up information etc.  
10. Significant hurdles in app 
development, although the 
trust does have an app 
development policy. Issues 
include IP rights, costs, security 
IT issues, content control etc  
11. We use PaediatricEmergencies 
app on a charity donated iPad, 
money and commissioning is 
difficult 
1. Approved spreadsheet from 
regional PICU (crashcall) on 
desktop PCs. 
2. We use medical apps but not 
with formal trust approval 
3. We use them but in a personal 
capacity 
4. Funding for simman app 
5. Regular 'Hackathons ' are held 
by the Innovation department. 
There are also a couple of IT 
guys/ IT company who have 
been commissioned by the 
trust to develop apps that are 
needed - recent info gathering 
by them- info given by 
trainees include critique on 
apps they already use e.g. PCO 
6. There is no mandated use of 
apps, it will vary for each 
individual 
  
 Table 4: Stage (i) site survey: Apps provided, recommended, locally designed  
 Provided on 
Institutional Device 
Recommended by Institution Locally led apps 
 
apple android apple android apple android 
Reference apps 
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BMJ best practise  0 0 0 1 0 0 
Local Reference 1 1 1 1 3 2 
Induction  1 1 3 2 0 0 
MedCalc  0 0 0 1 0 0 
MedHand  1 1 0 0 0 0 
Nervecentre 1 0 0 0 1 0 
Nice Guidance App  0 1 0 0 0 0 
RCH Clinical Guidance  0 1 0 0 0 0 
RxGuidelines 0 0 5 2 0 0 
UptoDate  1 1 1 1 0 0 
Resuscitation 
APLS  0 1 0 0 0 0 
Mersey Burns  0 1 0 1 0 0 
NeoMate  0 0 2 0 0 0 
PaediatricEmergencies  1 0 1 1 0 0 
Formulary 
BNF/BNFc  5 3 9 6 0 0 
Local formulary  0 1 3 3 0 0 
Yellow Card  0 1 0 0 0 0 
Antibiotic Guidance 
NHS Scotland antimicrobials  0 0 1 1 0 0 
Microguide  1 1 4 2 0 0 
Local Antibiotic Guidelines  1 1 5 5 3 2 
Advice 
HANDi  0 0 1 0 0 0 
NHS - Child Health 1 0 0 0 1 0 
Taking the ouch of Children's 
Emergency  
0 1 0 0 0 1 
Communication 
BleebPod  0 0 1 1 0 0 
NW Burns referral  0 0 1 0 0 0 
Local Communication App 1 1 0 0 0 0 
Miscellaneous 
Airvo 2  0 1 0 0 0 0 
Arrow EZ-IO  0 0 0 1 0 0 
Chameleon (game) 0 0 1 0 0 0 
Citizenaid  0 0 1 1 0 0 
POPS  0 0 1 1 1 1 
SimMon  1 1 0 0 0 0 
 
 Table 5: Stage (ii) individual clinician survey: Demographics  
Total Respondents  450  
Completion 419 (males 56%; female 44%) 
Average age 40 years 
93% 
United Kingdom & Republic 
of Ireland 
308 68% 
Rest of the World include 81 
German speaking response  
142 32% 
German speaking Survey 81 18% 
Doctors Total: 369 88% 
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Consultants (Attending) (227, (62%)) 
General Practitioners: (8, (2%)) 
Trainee Doctors: (134, (36%)) 
Other Healthcare 
Professionals 
50 12% 
Number of respondents that 
treat children with medical 
presentations 
334 80% 
Number German speaking 
respondents that treat 
children with medical 
presentations 
22 5% 
Number of respondents that 
treat children with trauma 
presentations 
234 56% 
Number German speaking 
respondents that treat 
children with trauma 
presentations 
26 6% 
Number of respondents that 
treat adults with medical 
presentations 
203 48% 
Number German speaking 
respondents that treat 
adults with medical 
presentations 
76 17% 
Number of respondents that 
treat adults with trauma 
presentations 
169 40% 
Number German speaking 
respondents that treat 
adults with trauma 
presentations 
57 13% 
 
 Table 6: Stage (ii) individual clinician survey: Personal mobile device type 
Personal Mobile Device Percentage 
Apple Device (iPhone/iPad) 71%, 
Android Device 29%, 
Blackberry 0.3% 
 
 Table 7: Stage (ii) individual clinician survey: number of medical apps per mobile 
device 
Number of Apps  Personal Mobile Device 
0 Apps 1% 
1-5 Apps 54% 
6-10 Apps 28% 
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11-15 Apps 11% 
16 or more Apps 6% 
 
 Table 8: Stage (ii) individual clinician survey: Individual mobile device  
 never Rarely weekly Daily 
medication formulary or drug 
reference 
123% 134% 26% 48% 
clinical score systems or 
medical calculator 
18% 24% 28% 30% 
disease diagnosis or 
management 
18% 33% 26% 23% 
procedure documentation 58% 23% 10% 9% 
CPD (Continuing Professional 
Development) or eportfolio 
27% 26% 35% 12% 
education (revision & 
learning) 
18% 23% 32% 27% 
calendar, rota 10% 7% 16% 67% 
password storage (login 
details) 
41% 18% 14% 27% 
email access (work email) 16% 4% 7% 73% 
staying in touch with 
colleagues 
9% 9% 18% 65% 
Social Media (Twitter, 
Facebook, etc) 
17% 11% 7% 65% 
web access 3% 5% 5% 88% 
 
 
 Table 9: Stage (ii) individual clinician survey: Medical Apps on Personal Device  
 
 
Names of Medical App on Personal Mobile Device Number of times 
listed 
Medical Reference Apps 
UpToDate 41 
Medscape 32 
Toxbase 22 
Growth charts 13 
Aid Diagnosia (AGN Fibel) 10 
Medstandards 8 
BiliApp 7 
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EMGuidance 5 
Induction 5 
NHS GG&C Childrens guideline app 5 
Paediatric care online 3 
Rx Guidelines 3 
AO Klassifikation 2 
Cardio Z 2 
Figure 1 2 
Genetics 4M 2 
NUH Guidelines app 2 
ÖGARI App 2 
Nchd Guide (nchd.ie) 2 
BCH KIDS 1 
Dynamed plus 1 
Elsevier Klinikleitfaeden (diverse) 1 
Harrisons Internal Medicine 1 
Ignaz - own guidelines on this 1 
Kittelcoach 1 
NICE guidance 1 
Notfallmedizin App 1 
Pediatric EM Morsels 1 
PICU life 1 
Pubmed 1 
RCEM app 1 
RCH Clinical Guidelines 1 
Septic arthritis 1 
Vitals 1 
Wells Score 1 
Formulary Apps 
BNF/BNFC 140 
Compendium Documed 7 
Arzneimittelbuch 3 
Arznei aktuell 1 
Arzneimittel Pocket 1 
Formulary 1 
 10-5  
MIMS 1 
Olchc formulary 1 
Tarascon – formulary 1 
UBQO paed formulary 1 
Resuscitation Medical Apps 
iResus 31 
Paediatric Emergencies 25 
Neomate 24 
Paeds ED 14 
APLS 6 
MyATLS 4 
Kinderanästhesie 3 
PediSTAT 3 
Emuk 2 
Pediatric Resuscitation 2 
Pedihelp 2 
burn calculator 1 
iArrest  1 
Jr calc from Scottish ambulance service 1 
PICU Drug calculator 1 
STRS retrieval service app (guidelines & drug calculator 
for resus drugs) 
1 
Medical Calculator Apps 
MDCalc 29 
Medcalc 28 
MedCalx.ch 18 
CliniCalc 15 
Mediquations  3 
Qxcalculate 2 
Calculate Qx 1 
drug dose calculators 1 
Medi calc 1 
Antibiotic Guideline Apps 
Microguide 44 
Antibiotica pc 1 
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Local antimicrobial guideline 1 
Simulation Apps 
SimMon 11 
Sim Monitor 2 
Miscelleanous Apps 
RCPCH CPD App 7 
AmiKo Desitin 3 
Smack Conference App 2 
1Password 1 
Cerner 1 
ESApp Personal 1 
Jext 1 
MDCoder 1 
Overcast - to listen to podcasts 1 
RCPCH Conference App 1 
WhatsApp 1 
 
 
 Table 10: Stage (ii) individual clinician survey: Favourite Apps on Personal Device 
Name of Favourite Medical App on Personal Mobile 
Device 
Number of times 
listed 
BNF/BNFc 68 
Uptodate 24 
PaediatricEmergencies 17 
MDCalc 15 
NeoMate 12 
Medscape 10 
MedCalX 10 
Aid Diagnosia (AGN Fibel) 9 
Medstandards 9 
Paediatric care online 7 
MedCalc 7 
Microguide 7 
MerseyBurns  7 
Clincalc 5 
Paeds ED 5 
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EMGuidance 4 
Qxcalculate 3 
Induction 3 
Toxbase 3 
BiliApp 3 
PediSTAT 3 
STRS 3 
Dynamed 2 
Figure 1 2 
Pedihelp 2 
Opioid Calculator 2 
Smack 2 
Compendium 2 
Growth Charts 2 
iResus 2 
NHS GG&C Childrens guideline app 2 
PICU calculator 2 
PICU doctor 2 
POPS 2 
RCH Clinical Guidelines 2 
SimMon 2 
AmiKo 1 
Cerener 1 
Dr House 1 
EMed.ie 1 
Jr Calc from Scottish ambulance service 1 
Mediquations 1 
nchd.ie 1 
Olchc app 1 
Pediatric Resuscitation 1 
Read by QXMD 1 
safeguarding children4U 1 
Stanford EPIC Haiku 1 
antibiotic guidelines 1 
BCH KIDS 1 
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Bmj best practice 1 
Cardio Secur pro 1 
Documed 1 
Don't forget the bubbles 1 
ECG 1 
Em:rap 1 
Emuk 1 
Ganz 1 
guidelines.ch 1 
Heartpedia 1 
ICD-10 1 
NICEguidance 1 
Notfall Medizin App.de 1 
ÖGARI App 1 
OHCM 1 
Orthoflow 1 
PAedEmerg 1 
Paeds drug 1 
Pediatric EM Morsels 1 
RCEM learning 1 
SIM MONITOR 1 
Twitter 1 
Vitals 1 
 
 
 Table 11: Stage (ii) individual clinician survey: Medical Apps on Institutional Device 
Medical App on the Institutional Mobile Device Number of times listed 
BNF/BNFc 8 
PaediatricEmergencies 4 
Uptodate 4 
Drug dose calculator  2 
Nervecentre 2 
RCH Clinical Guidelines 2 
antibiotic guidelines 1 
Clinical key 1 
klinische richtlinien 1 
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microapp 1 
Clincalc 1 
Compendium 1 
essential anatomy 5 1 
GMC my CPD 1 
guidelines 1 
ICU notes 1 
Induction  1 
Lungenfunktion i-pocketcards 1 
medscape 1 
mt atlas 1 
myotomes 1 
NHS eportfolio 1 
NUH Clinical Guidelines 1 
Paeds ECG 1 
Pubmed on tab 1 
RCEM learning 1 
Stanford EPIC Haiku 1 
 
 Table 12: Stage (ii) individual clinician survey: Recommended Medical Apps  
Name of App Number of time recommended 
BNF/BNFc 55 
Microguide 44 
Uptodate 27 
PaediatricEmergencies 8 
Induction 5 
Alder Hey Antimicrobial 4 
cerner 4 
EM Guidance 4 
medstandards 4 
NHS Scotland antimicrobials app 4 
Stanford EPIC Haiku 4 
Dynamed plus  3 
paediatric care online 3 
PICU Calculator 3 
RxGuidelines 3 
 10-5  
Burns referral  2 
NeoMate 2 
NUH guidelines 2 
Antimicrobial guidelines app 1 
Bartshealth eCPD for statman  1 
BMJBestPractice 1 
Edinburgh EM app 1 
Ganz 1 
HANDi App 1 
Imperial antibiotics  1 
LinkedIn  1 
Olchc formulary 1 
RCH Clinical Guidelines 1 
  
 
 Table 13: Prescribing 
Prescribing  PERUKI 
Site 
survey 
RCEM 
individual 
clinician 
survey  
RCEM 
individual 
clinician 
survey 
UK & 
Ireland 
RCEM 
individual 
clinician 
survey 
Austria, 
Germany 
and 
Switzerland 
Total Responses 46 325 221 63 
Use of a paper-based formulary book (eg 
British National Formulary or equivalent) 
100% 47% 64% 10% 
Use of a personal Smartphone to look up 
the dose on the electronic formulary (eg 
British National Formulary or equivalent) 
80% 59% 61% 54% 
Use of institutional mobile device to look 
up the dose on the electronic formulary 
(eg British National Formulary or 
equivalent) 
48% 16% 10% 33% 
Use of an online search engine to check 
the dose 
37% 12% 8% 29% 
Use of local guidelines (paper version) 54% 22% 24% 8% 
Use of local guidelines (electronic version) 94% 48% 55% 44% 
Other  0% 6% 7% 2% 
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 Table 14: Resuscitation in Children and Adults 
Resus Child PERUKI 
site 
survey 
RCEM 
individual 
clinician 
survey 
RCEM 
individual 
clinician 
survey: 
UK & 
Ireland 
RCEM 
individual 
clinician 
survey: 
Germany, 
Austria, 
Switzerland 
Resus Adult PERUKI 
site 
survey 
RCEM 
individual 
clinician 
survey 
RCEM 
individual 
clinician 
survey: 
UK & 
Ireland 
RCEM 
individual 
clinician 
survey: 
Germany, 
Austria, 
Switzerland 
Total 46 326 221 64 Total 46 325 220 65 
Total that 
treat 
Children 
46 290 217 35 - - - - - 
- - - - - Total that 
treat Adults 
23 143 121 65 
We will use 
a Broselow 
Tape when 
the child 
arrives 
4% 9% 4% 14% - - - - - 
We will use 
the 
WETFLAG 
calculation 
as per APLS 
& follow 
the APLS 
algorithm 
on the Wall 
87% 63% 79% 20% We will use 
ALS 
(advanced 
Life 
Support) 
algorithm 
on the Wall 
37% 27% 25% 42% 
We will use 
the Medical 
App on our 
personal 
mobile 
device 
28% 33% 34% 33% We will use 
the Medical 
App on our 
personal 
mobile 
device 
11% 10% 9% 11% 
We will use 
the Medical 
App on our 
institutional 
mobile 
device 
13% 4% 5% 0% We will use 
the Medical 
App on our 
institutional 
mobile 
device 
2% 1% 1% 3% 
We will 
print out 
the 
institutional 
Excel or 
similar age 
and weight-
based resus 
medicine 
crib sheet 
46% 22% 30% 6% We will 
print out 
the 
institutional 
Excel or 
similar 
resus 
medicine 
crib sheet 
0% 3% 4% 3% 
We will use 
the 
institutional 
aged base 
medicine 
folder with 
laminated 
age and 
weight-
based crib 
sheets 
46% 28% 33% 13% We will use 
the 
institutional 
medicine 
folder with 
laminated 
ALS based 
crib sheets 
11% 10% 10% 17% 
We will use 
the Medical 
App on our 
personal 
mobile 
device get 
any 
infusions 
(eg 
9% 13% 14% 9% We will use 
the Medical 
App on my 
personal 
mobile 
device to 
get any 
infusions 
(eg 
4% 4% 4% 6% 
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inotropes) 
ready 
inotropes) 
ready 
We will use 
the Medical 
App on our 
institutional 
mobile 
device to 
get any 
infusions 
(eg 
inotrope) 
ready 
2% 3% 4% 3% We will use 
the Medical 
App on my 
institutional 
mobile 
device to 
get any 
infusions 
(eg 
inotropes) 
ready 
2% 1% 0% 5% 
We will use 
the 
institutional 
aged base 
medicine 
folder with 
laminated 
age and 
weight-
based crib 
sheets to 
get any 
infusions 
(eg 
inotrope) 
ready 
33% 22% 25% 11% We will use 
the 
institutional 
medicine 
folder with 
laminated 
crib sheets 
to get any 
infusions 
(eg 
inotropes) 
ready 
24% 10% 9% 17% 
From 
memory 
- 6% 5% 8% From 
memory 
- 23% 13% 55% 
 
 
 
10.3 Appendix 3: Surveys 
 
 
 1. Stage (i) site survey questionnaire 
 
1. Could you kindly select your PERUKI site from the list below (listed alphabetically), 
otherwise select “other”. 
 
2. Does your institution provide free wifi or internet access to use Apps at work (both 
for institutional and personal mobile devices)? 
a. Yes 
b. No 
c. Other (please specify) 
 
2. Does your institution have a mobile device policy? 
a. Yes 
b. No 
 
3. Does your institution's mobile device policy allow the use of personal mobile devices 
eg smartphones, etc in the clinical environment? 
a. Yes 
b. No 
c. No, but tolerated 
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d. Other 
 
4. Does your institution's mobile device policy allow the use of institutional mobile 
devices eg smartphones, tablets etc in the clinical environment? 
a. Yes 
b. No 
c. No, not allowed but tolerated 
 
5. What guidance if any does your institution provide Medical Staff regarding the use of 
Medical Apps on either the institutional or personal device in the clinical 
environment? 
 
6. Does your institution provide mobile devices eg mobile phones, smartphones, 
tablets, etc for communication and to run Apps? 
a. Yes 
b. No 
 
7. Does your institution provide their staff with a smartphone or other mobile device to 
run Medical Apps? Select all relevant 
a. Blackberry 
b. Android Phone 
c. Android Tablet 
d. iPhone 
e. iPad 
f. Other (please specify) 
 
8. How many Medical Apps are provided on your Institutional Device, if any? 
a. 0 
b. 1-5 
c. 6-10 
d. 11-15 
e. 16-20 
f. more than 20 
 
9. Which APPLE Medical Apps are provided on your trust or institution device (e.g. 
electronic formulary, drug dose calculators, clinical guidelines, etc)? 
a. Name of App 
b. Name of App 
c. Name of App 
d. Name of App 
e. Name of App 
 
10. Which ANDROID Medical Apps are provided on your trust or institution device (e.g. 
electronic formulary, drug dose calculators, clinical guidelines, etc)? 
a. Name of App 
b. Name of App 
c. Name of App 
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d. Name of App 
e. Name of App 
 
11. Which BLACKBERRY Medical Apps are provided on your trust or institution device 
(e.g. electronic formulary, drug dose calculators, clinical guidelines, etc)? 
a. Name of App 
b. Name of App 
c. Name of App 
d. Name of App 
e. Name of App 
 
12. Do the Medical Apps on your institutional device require an internet or wifi 
connection at the point of use, eg electronic formulary, electronic guidelines, etc? 
a. No, none require an Internet connection 
b. Yes, some require an Internet connection 
c. Yes, all require an Internet connection 
d. Not Applicable 
e. Other  
 
13. Does your institution recommend specific local, regional network, national or 
international Medical Apps (Hospital App, Micro guide, Burns, Retrieval, PICU App 
etc) for clinicians to run on their personal smartphone or mobile device? 
a. Yes 
b. No 
 
14. What is the process for your institution to recommend a Medical App? 
 
15. Are these recommended Medical Apps available for free to download? 
a. No, have to be bought by individual 
b. Yes, free for all to download 
c. Yes, only for free for clinician working at the trust to download 
d. Some are for free to download, other have to be bought by the individual 
e. Not applicable 
f. Other  
 
16. Does your institution provide any training regarding the use of recommended 
Medical Apps in the Clinical Environment, especially regarding perception by 
patients and relatives? 
a. Yes 
b. No 
c. Not applicable 
 
17. If yes, could you explain 
 
18. Which ANDROID Medical Apps are recommended by your institution? 
a. Name of App 
b. Name of App 
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c. Name of App 
d. Name of App 
e. Name of App 
 
19. Which APPLE Medical Apps are recommended by your institution? 
a. Name of App 
b. Name of App 
c. Name of App 
d. Name of App 
e. Name of App 
 
20. Which BLACKBERRY Medical Apps are recommended by your institution? 
a. Name of App 
b. Name of App 
c. Name of App 
d. Name of App 
e. Name of App 
 
21. Has your department designed or commissioned specific local or regional network 
Medical Apps (Hospital App, Micro guide, Burns, Retrieval, PICU App etc) for 
clinicians to run on their personal smartphone or mobile device? 
a. Yes 
b. No 
 
22. What was the design or commissioning process for the Medical App? 
a. Medical App designed in house by clinician 
b. Medical App designed in house by clinician with IT department 
c. Medical App designed in house by clinician and university 
d. Medical App designed outsourced to App design company 
e. Other (please specify) 
 
23. Which APPLE Medical Apps (if any) has your Emergency Department designed or 
commissioned? 
a. Name/Topic of App 
b. Name/Topic of App 
c. Name/Topic of App 
d. Name/Topic of App 
e. Name/Topic of App 
 
24. Which ANDROID Medical Apps (if any) has your Emergency Department designed or 
commissioned? 
a. Name/Topic of App 
b. Name/Topic of App 
c. Name/Topic of App 
d. Name/Topic of App 
e. Name/Topic of App 
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25. Has your department encountered any barriers regarding the use of Medical Apps in 
the Clinical Environment in your department? Select all relevant 
a. Unable to comment as we do not use Medical Apps in our Department 
b. Colleagues 
c. Institution 
d. Patients 
e. Technical 
f. Internet or Wifi Connection to run Medical App 
g. Price (cost to create Medical Apps) 
h. Price (cost to download Medical Apps) 
i. Other  
 
26. What has enabled the use of Medical Apps in the Clinical Environment in your 
setting? Select all relevant 
a. Unable to comment as we do not use Medical Apps in our Department 
b. Colleagues 
c. Institution 
d. Patients 
e. Technical 
f. Internet or Wifi Connection to run Medical App 
g. Price (free to download) 
h. Price (funding to create Medical Apps) 
i. Other  
 
27. Are you aware of any patients that has suffered harm, due to the use of Medical 
Apps as part of their care in your department (e.g. wrong drug dose, etc)? Select all 
relevant 
a. No, harm 
b. Yes, Serious Adverse Event (any untoward medical occurrence(s) that result 
in death, hospitalisation or prolongation of existing hospitalisation, persistent 
or significant disability/incapacity or a congenital anomaly or birth defect 
associated with treatment). 
c. Yes, Adverse Event (any unfavourable and unintended signs, including 
abnormal laboratory results, symptoms or a disease associated with 
treatment). 
d. Other  
 
28. If you answered Serious Adverse Event, could you tell us what the problem was? 
Otherwise move on to next question. 
 
29. If you answered Adverse Event, could you tell us what the problem was? Otherwise 
move on to next question. 
 
30. When prescribing the following are acceptable options at your institution to check 
the dosing regime. Select all relevant 
a. Use of a paper based formulary book (eg British National Formulary or 
equivalent) 
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b. Use of a personal Smartphone to look up the dose on the electronic 
formulary (eg British National Formulary or equivalent) 
c. Use of institutional mobile device to look up the dose on the electronic 
formulary (eg British National Formulary or equivalent) 
d. Use of an online search engine to check the dose 
e. Use of local guidelines (paper version) 
f. Use of local guidelines (electronic version) 
g. Other  
 
31. In resus (sick patient in a time critical situation). There has been a pre-alert of a 2 
year old arriving in 5 minutes seriously injured/unwell. To get yourself ready. Select 
all relevant 
a. We do not treat Children 
b. We will use a Broselow Tape when the child arrives 
c. We will use the WETFLAG calculation as per APLS & follow the APLS algorithm 
on the Wall 
d. We will use the Medical App on our personal mobile device 
e. We will use the Medical App on our insitutional mobile device 
f. We will print out the institutional Excel or similar age and weight based resus 
medicine crib sheet 
g. We will use the institutional aged base medicine folder with laminated age 
and weight based crib sheets 
h. We will use the Medical App on our personal mobile device get any infusions 
(eg inotropes) ready 
i. We will use the Medical App on our institutional mobile device to get any 
infusions (eg inotropes) ready 
j. We will use the institutional aged base medicine folder with laminated age 
and weight based crib sheets to get any infusions 
k. (eg inotropes) ready 
l. Other  
 
32. In resus (sick patient in a time critical situation). There has been a pre-alert of a 30 
year old arriving 5 minutes seriously unwell/injured. To get yourself ready. Select all 
relevant 
a. We do not treat adults 
b. We will use ALS (advanced Life Support) algorithm on the Wall 
c. We will use the Medical App on our personal mobile device 
d. We will use the Medical App on our institutional mobile device 
e. We will print out the institutional Excel or similar resus medicine crib sheet 
f. We will use the institutional medicine folder with laminated ALS based crib 
sheets 
g. We will use the Medical App on my personal mobile device to get any 
infusions (eg inotropes) ready 
h. We will use the Medical App on my institutional mobile device to get any 
infusions (eg inotropes) ready 
i. We will use the institutional medicine folder with laminated crib sheets to get 
any infusions (eg inotropes) ready 
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j. Other  
 
 
 
 2. Stage (ii) individual clinician survey questionnaire 
 
1. Where do you work? 
a. I work in the United Kingdom or Ireland  
b. Any other country  
 
2. 4. In what country do you work?  
 
3. How old are you?  
a. Years  
 
4. What is your gender?  
a. Female  
b. Male 
c. Other  
 
5. Please select the type of patients you normally treat. Select all relevant  
a. Adults (Medical)  
b. Children (Medical)  
c. Adult (Trauma)  
d. Children (Trauma)  
 
6. Are you a medical doctor or medical Student?  
a. Yes, I am a medical doctor or medical student 
b. No, other healthcare professional  
 
7. What is your role? 
a. Consultant (or equivalent on specialist register) 
b. General Practitioner (or equivalent on specialist register) 
c. Middle Grade Doctor (Staff grade or equivalent) 
d. Middle Grade Doctor (Registrar - ST4-ST8 or equivalent) 
e. Junior Medical Doctor (Senior House Officer - ST3 or equivalent)  
f. Junior Medical Doctor (Senior House Officer - ST1- ST2 or equivalent)  
g. Junior Medical Doctor (F2 or equivalent) 
h. F1 (Preregistration House Officer or equivalent) 
i. Medical Student 
j. Other 
 
8. What is your Specialty (or specialty training program if trainee)? Select all relevant  
a. Anaesthetics 
b. Emergency Medicine 
c. Emergency Medicine & Paediatric Emergency Medicine (subspecialty 
training) 
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d. General Internal Medicine 
e. General Practice 
f. Intensive Care 
g. Paediatrics (General Paediatrics) 
h. Paediatrics & Paediatric Emergency Medicine (subspecialty training) 
i. Paediatric Intensive Care 
j. Paediatric Surgery 
k. Surgery 
l. Trauma & Orthopaedics 
m. Other  
 
9. What is your role?  
a. Paramedic  
b. Nurse Practitioner 
c. Advanced Nurse Practitioner (ANP)  
d. Emergency Room Nurse Practitioner (ENP)  
e. Paediatric Advanced Nurse Practitioner  
f. Nurse 
g. Other  
 
10. In relation to the following types of Apps and mobile device functions, please 
indicate how often you use them to help you with your clinical and educational 
activities: 
Select all relevant  
a. medication formulary or drug reference  
b. clinical score systems or medical calculator  
c. disease diagnosis or management  
d. procedure documentation  
e. CPD (Continuing Professional Development) or eportfolio  
f. education (revision & learning)  
g. calendar, rota  
h. password storage (login details)  
i. email access (work email)  
j. staying in touch with colleagues  
k. Social Media (Twitter, Facebook, etc)  
l. web access  
m. other (please detail in comment box)  
n. Other  
 
11. Does your institution provide free wifi or internet access to use Apps at work (both 
on the institutional and your personal mobile devices)?  
a. Yes 
No 
Other  
 
12. Are you aware of your institution's mobile device policy?  
a. Yes  
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b. No  
 
13. Does your institution's mobile device policy allow the use of a PERSONAL mobile 
devices eg smartphones, etc in the clinical environment?  
a. Yes 
b. No 
c. No, but tolerated I do not know  
d. Other  
 
14. Does your institution's mobile device policy allow the use of an INSTITUTIONAL 
mobile devices eg smartphone, tablet etc in the clinical environment?  
a. Yes 
b. No 
c. No, but tolerated 
d. I do not know 
e. I do not know, as INSTITUTION does not provide mobile device  
f. Other  
 
15. Do you use Medical Apps on your PERSONAL mobile device?  
a. Yes  
b. No  
 
16. How many Medical Apps do you have on your personal mobile device (smartphone) 
per device?  
a. 0  
b. 1-5 
c. 6-10 
d. 11-15 
e. 16-20 
f. more than 20  
 
17.  Which type of mobile device do you use?  
a. Blackberry  
b. iPhone/iPad 
c. Android Phone/Tablet  
d. Other  
 
18.  Which BLACKBERRY Medical Apps do you have on your own personal device (e.g. 
electronic formulary, drug dose calculators, clinical guidelines, etc)? 
List them in order of frequency of use (most often used first).  
a. Name of App 
b. Name of App 
c. Name of App 
d. Name of App 
e. Name of App 
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19. Which is your FAVOURITE BLACKBERRY Medical App, that you love to use or you 
would highly recommend to a colleague?  
a. Name of App 
b. Name of App 
c. Name of App 
d. Name of App 
e. Name of App 
 
20. Which APPLE Medical Apps do you have on your own personal device (e.g. electronic 
formulary, drug dose calculators, clinical guidelines, etc)? 
List them in order of frequency of use (most often used first).  
a. Name of App 
b. Name of App 
c. Name of App 
d. Name of App 
e. Name of App 
 
21. Which is your FAVOURITE APPLE Medical App, that you love to use or you would 
highly recommend to a colleague?  
a. Name of App 
b. Name of App 
c. Name of App 
d. Name of App 
e. Name of App 
 
22. Which ANDROID Medical Apps do you have on your own personal device(e.g. 
electronic formulary, drug dose calculators, clinical guidelines, etc)? 
List them in order of frequency of use (most often used first).  
a. Name of App 
b. Name of App 
c. Name of App 
d. Name of App 
e. Name of App 
 
23. Which is your FAVOURITE ANDROID Medical App, that you love to use or you would 
highly recommend to a colleague?  
a. Name of App 
b. Name of App 
c. Name of App 
d. Name of App 
e. Name of App 
 
24. Are you provided with an INSTITUTIONAL device to run Medical Apps?  
a. Yes  
b. No  
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25. How many Medical Apps are there on your institutional mobile device (smartphone, 
tablet, etc)?  
a. 0  
b. 1-5 
c. 6-10 
d. 11-15 
e. 16-20 
f. more than 20  
 
26. What type INSTITUTIONAL mobile devices are you provided with to run Medical 
Apps?  
a. Blackberry  
b. iPhone/iPad 
c. Android Phone/Tablet  
d. Other  
 
27. Which APPLE Medical Apps are provided on your trust or institution device (e.g. 
electronic formulary, drug dose calculators, clinical guidelines, etc)? 
List them in order of frequency of use (most often used first).  
a. Name of App 
b. Name of App 
c. Name of App 
d. Name of App 
e. Name of App 
 
28. Which ANDROID Medical Apps are provided on your trust or institution device (e.g. 
electronic formulary, drug dose calculators, clinical guidelines, etc)? 
List them in order of frequency of use (most often used first).  
a. Name of App 
b. Name of App 
c. Name of App 
d. Name of App 
e. Name of App 
 
29. Which BLACKBERRY Medical Apps are provided on your trust or institution device 
(e.g. electronic formulary, drug dose calculators, clinical guidelines, etc)? 
List them in order of frequency of use (most often used first).  
a. Name of App 
b. Name of App 
c. Name of App 
d. Name of App 
e. Name of App 
 
30. Does your Institution recommend you Medical Apps to use on your personal mobile 
device?  
a. No  
b. Yes and they are for free to download for staff  
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c. Yes, but I have to pay for them 
d. Yes some are free and some I have to pay for  
e. I do not know  
 
31. Which APPLE Medical Apps does your institution recommend?  
a. Name of App 
b. Name of App 
c. Name of App 
d. Name of App 
e. Name of App 
 
32. Which ANDROID Medical Apps does your institution recommend?  
a. Name of App 
b. Name of App 
c. Name of App 
d. Name of App 
e. Name of App 
 
33. Which BLACKBERRY Medical Apps does your institution recommend?  
a. Name of App 
b. Name of App 
c. Name of App 
d. Name of App 
e. Name of App 
 
34. When asked to prescribe a drug that you need to check the dose regimen for.... 
Select all relevant  
a. I will use a paper based formulary book (eg British National Formulary or 
equivalent)  
b. I will use my personal Smartphone to look up the dose on the electronic 
formulary (eg British National Formulary or equivalent)  
c. I will use an online search engine to check the dose  
d. I will use the institutional mobile device to look up the dose on the electronic 
formulary (eg British National Formulary or equivalent)  
e. I will use local guidelines (paper version) 
f. I will use local guidelines (electronic version)  
g. Other (please specify) 
 
35. You are in resus (sick patient in a time critical situation). There has been a pre-alert 
of a 2 year old arriving in 5 minutes seriously injured/unwell. To get yourself ready 
Select all relevant  
a. I do not treat Children  
b. I will use a Broselow Tape  
c. I will use the WETFLAG calculation as per APLS & follow the APLS algorithm 
on the Wall  
d. I will use the Medical App on my personal mobile device  
e. I will use the Medical App on the institutional mobile device  
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f. I will print out the institutional Excel or similar age and weight based resus 
medicine crib sheet  
g. I will use the institutional aged base medicine folder with laminated age and 
weight based crib sheets  
h. I will use the Medical App on my personal mobile device get any infusions (eg 
inotropes) ready  
i. I will use the Medical App on my institutional mobile device to get any 
infusions (eg inotropes) ready  
j. I will use the institutional aged base medicine folder with laminated age and 
weight based crib sheets to get any infusions (eg inotropes) ready  
k. I know all the calculations and dosages  
l. From memory 
m. Other (please specify)  
 
36. You are in resus (sick patient in a time critical situation). There has been a pre-alert 
of a 30 year old arriving in 5 minutes seriously unwell/injured. To get yourself ready 
Select all relevant  
a. I do not treat Adults 
b. I will use ALS (Advanced Life Support) algorithm on the Wall 
c. I will use the Medical App on my personal mobile device 
d. I will use the Medical App on the institutional mobile device 
e. I will print out the institutional Excel or similar resus medicine crib sheet 
f. I will use the institutional medicine folder with laminated ALS based crib 
sheets 
g. I will use the Medical App on my personal mobile device to get any infusions 
(eg inotropes) ready 
h. I will use the Medical App on the institutional mobile device to get any 
infusions (eg inotropes) ready 
i. I will use the institutional medicine folder with laminated crib sheets to get 
any infusions (eg inotropes) ready I know all the calculations and dosages  
j. From memory 
k. Other (please specify) 
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